Dear readers, during the New Year's rush, it may have escaped your attention that on 29 December, the Amendment to the Medicines Act was published in the Collection of Laws, in volume 203 under number 456/2023 Coll. Barring one exception, which we discuss below, the amendment already went into effect on 1 January 2024.

Walless has advised the Med Grupe shareholders on the sale of their pan-Baltic dental equipment distribution business to Straumann. Sorainen reportedly advised the Straumann Group.

A long-awaited amendment to the Czech Medicines Act came into force on 1 January 2024. What practical impact will it have?

Soltysinski Kawecki & Szlezak has advised Straumann Holding on its acquisition of Schmidt Dental from Oliver Schmidt. Burzak Okon and Partners reportedly advised Schmidt on the sale.

There has been much discussion about protracted shortages of critical medicines in the Czech Republic over the last couple of months. Many national measures have been adopted. At the European Union level,the Voluntary Solidarity Mechanism for medicines has been put in place.

PRK Partners has advised Affimed on its successful divestment of AbCheck to Flagship Pioneering company Ampersand Biomedicines.